Yasumatsu, Ryuji

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G., Psyrri, A., Basté, N., Neupane, P., Bratland, Å., et al. (2019) · The Lancet

Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers

Cited by 3,336

Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma

Masuda, M., Ruan, H.-Y., Ito, A., Nakashima, T., Toh, S., Wakasaki, T., Yasumatsu, R., Kutratomi, Y., Komune, S., & Weinstein, I. B. (2007) · Oral Oncology

Angiogenesis and VEGF in CancerCytokine Signaling Pathways and Interactions

Cited by 33